Pamapol Quote - 0LXG | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
UK
LSE
Pamapol Sa (0LXG) Share Price

Pamapol Sa (0LXG)

0.94

0.00

( 0.00% )

Updated: 18:00:00

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

0.94

Bid

0.00

Ask

0.00

Volume

0.00

0.00 Day's Range 0.00

0.94 52 Week Range 0.94

Market Cap

Previous Close

0.94

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

0.00

Shares Outstanding

34,750,000

Dividend Yield

-

PE Ratio

3.05

Earnings Per Share (EPS)

0.31

Revenue

992.13M

Net Profit

10.69M

Sector

Can Fruit,veg,presrv,jam,jel

Industry

Meats And Meat Products-whsl

Website

www.pamapol.com.pl

Headquarters

Rusiec, Pol

Founded

1992

Pamapol Sa is listed in the Can Fruit,veg,presrv,jam,jel sector of the London Stock Exchange with ticker 0LXG. The last closing price for Pamapol was PLN0.94. Over the last year, Pamapol shares have traded in a share price range of PLN 0.94 to PLN 0.94.

Pamapol currently has 34,750,000 shares outstanding. The market capitalization of Pamapol is PLN32.67 million. Pamapol has a price to earnings ratio (PE ratio) of 3.05.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.94	0.94	0.94	0	0	DE
4	0	0	0.94	0.94	0.94	0	0	DE
12	0	0	0.94	0.94	0.94	0	0	DE
26	0	0	0.94	0.94	0.94	0	0	DE
52	0	0	0.94	0.94	0.94	0	0	DE
156	0	0	0.94	0.94	0.94	0	0	DE
260	0	0	0.94	0.94	0.94	0	0	DE

0LXG - Frequently Asked Questions (FAQ)

What is the current Pamapol share price?

The current share price of Pamapol is PLN 0.94

How many Pamapol shares are in issue?

Pamapol has 34,750,000 shares in issue

What is the market cap of Pamapol?

The market capitalisation of Pamapol is PLN 32.67M

What is the 1 year trading range for Pamapol share price?

Pamapol has traded in the range of PLN 0.94 to PLN 0.94 during the past year

What is the PE ratio of Pamapol?

The price to earnings ratio of Pamapol is 3.05

What is the cash to sales ratio of Pamapol?

The cash to sales ratio of Pamapol is 0.03

What is the reporting currency for Pamapol?

Pamapol reports financial results in PLN

What is the latest annual turnover for Pamapol?

The latest annual turnover of Pamapol is PLN 992.13M

What is the latest annual profit for Pamapol?

The latest annual profit of Pamapol is PLN 10.69M

What is the registered address of Pamapol?

The registered address for Pamapol is UL. WIELUNSKA 2, RUSIEC, 97-438

What is the Pamapol website address?

The website address for Pamapol is www.pamapol.com.pl

Which industry sector does Pamapol operate in?

Pamapol operates in the MEATS AND MEAT PRODUCTS-WHSL sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
XSGXeros Technology Group Plc	0.70p (33.33%)	5.29M
SYMESupply@me Capital Plc	0.0035p (27.27%)	1.12M
OBDOxford Biodynamics Plc	0.625p (25.00%)	85.09M
STXShield Therapeutics Plc	3.35p (17.54%)	5.13M
ASHIAshington Innovation Plc	0.85p (13.33%)	100k
KRPZKropz Plc	0.90p (-21.74%)	127.58k
PRDPredator Oil & Gas Holdings Plc	4.35p (-20.18%)	11.77M
ZENZenith Energy Ltd.	7.85p (-14.21%)	1.03M
INDIIndus Gas Limited	7.00p (-12.50%)	253.97k
ONCOncimmune Holdings Plc	9.00p (-11.76%)	45.46k
NTVONativo Resources Plc	0.0017p (0.00%)	411.93M
OBDOxford Biodynamics Plc	0.625p (25.00%)	85.09M
MSMNMosman Oil And Gas Limited	0.0425p (-2.30%)	59.88M
WBIWoodbois Limited	0.085p (3.03%)	48.38M
TM1Technology Minerals Plc	0.115p (-4.96%)	48.09M

TommyJ7651

TommyJ7651 5 minutes ago

Just something to take note of here. I have been following the comments received for Springpole on the Federal project website/portal:

https://iaac-aeic.gc.ca/050/evaluations/proj/80149/contributions

There are have been many letters of support coming in for Springpole f

sab63090

sab63090 10 minutes ago

Tom:
Your experience of more than 14 years sure has me beat by more than 10 1/2 years. Logical support levels have been consistently broken and lead me to believe that the short sellers are still in control (along with the market makers making $$$ in their partnership with them).

gotmilk

gotmilk 11 minutes ago

Materials to build artificial reefs into the Mediterranean Sea.

Concrete

To be responsible for disposing of unexploded munitions...
Rebuilding Gaza into a mecca for jobs and tourism...
...to turn it into “The Riviera of the Middle East.”

ht

nowwhat2

nowwhat2 16 minutes ago

February 3rd and 4th https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175749348

https://investorshub.advfn.com/uimage/uploads/2025/2/5/vamecrace_@_3_5y_downgap_chan.jpg

Tuesday Feb. the 4th
https://investorshub.advfn.

meshcan

meshcan 19 minutes ago

$215M and with that only ELTP can be over $2 pps

Stino2

Stino2 29 minutes ago

The following company's did a RS and have sunk very deep: BNGO, MULLEN, JAGX, ADAP, OCGN, NKLA etc....🤑

Stino2

Stino2 34 minutes ago

25% I have left and also this company doesn't answer their mails!!😪

Stino2

Stino2 35 minutes ago

We wil see today???

Biotechotcguy

Biotechotcguy 40 minutes ago

This is getting juicy!!!!!

infamous

infamous 45 minutes ago

so much for compliance again. what a trap this is

misterfishman

misterfishman 47 minutes ago

bbotcs

bbotcs 52 minutes ago

al44: That should result in a lawsuit.

bbotcs

bbotcs 54 minutes ago

lj: SMCI
Has it finally bottomed, or will it retest the recent low of $25 and change? Stay tuned.
Thank you for mentioning the AMD calls. Will check them out today (Wednesday).

leavetheguntakethecannolis

leavetheguntakethecannolis 55 minutes ago

A reminder for all.

https://www.beam-med.com/

Brain

Epilepsy is the most prevalent serious neurologic condition in the world, affecting about 70 million people. Unfortunately, 30%-40% of those patients are afflicted with drug resistant epilepsy, meaning t

muee88

muee88 56 minutes ago

You’re welcome, no problem at all

p0 56 minutes ago

World’s First Chikungunya Vaccine, IXCHIQ
Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®

Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®

February

bbotcs

bbotcs 57 minutes ago

lj; mid-40s with a brisk breeze barely felt like the mid-30's!

bbotcs

bbotcs 58 minutes ago

lj: Oil price was down on Tuesday morning but the big oil stocks were up!

DJPele

DJPele 1 hour ago

Much appreciated Muee! Although I did trust your initial post, it does help seeing it's full contents.

CaptainObvious

CaptainObvious 1 hour ago

Something is, that's for sure

zino

zino 1 hour ago

Great advice...if we get the right Quant Merger this will explode and could turn into a
potential Nasdaq uplisting...Just look at Rgti and its run Quant related and they're raising money so easily to the tune of 15O Million...was a penny stock few months back

pgsd

pgsd 1 hour ago

Typical for anything related to DCVax lol

It is included in the list of Proposed 24-25 HC Drugs:

In the alphabetic order from the list it is listed as 'Brain cancer vaccine' which is then crossed out and Murcidencel is added...

https://investorshub.advfn

muee88

muee88 1 hour ago

Also, the Proposed 24-25 HC drug list is alphabetical, but Murcidencel is listed under the Bs because “Brain Cancer Vaccine” is crossed out and replaced with Murcidencel.

TurboMountain96

TurboMountain96 1 hour ago

Frankly, we are the original MEGA, Make Elite Great Again. We had that slogan long before Trump entered politics or plagiarized from Ronald Reagan, who originally started Make America Great Again. So to that end, maybe to support the stockholders, our MEGA, we’re going to build a wall of needle move

RichieBoy

RichieBoy 1 hour ago

Only stating the patently obvious here...

When AFFU's dilution stops, the share price contraction stops. Just that simple. I get a strong sense the company is intentionally stalling for that reason. Mike Balkin and AFFU's other board member(s?) don't want to waste material event comp

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions